Clinical Trial Update: Determine the Dose-dependent Efficacy and Safety of EC-18 in Patients With Moderate to Severe Atopic Dermatitis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update evaluating the dose-dependent efficacy and safety of EC-18 in adults with moderate to severe Atopic Dermatitis; recruitment is n…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• EC-18

Snippet

Sponsor: Enzychem Lifesciences Corporation | Conditions: Atopic Dermatitis | Phase 2 | Status: NOT_YET_RECRUITING